1. Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice. Issue 1 (2nd January 2021) Authors: Zackova, Daniela; Klamova, Hana; Belohlavkova, Petra; Stejskal, Lukas; Necasova, Tereza; Semerad, Lukas; Weinbergerova, Barbora; Srbova, Dana; Voglova, Jaroslava; Cicatkova, Petra; Sustkova, Zuzana; Hornak, Tomas; Baranova, Jana; Prochazkova, Jirina; Mayer, Jiri Journal: Leukemia & lymphoma Issue: Volume 62:Issue 1(2021) Page Start: 194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗